There is growing evidence for crosstalk between septin filaments and actin cytoskeleton which is regulated by Rho family of GTPases. Here we show that active Rho disrupts septin filament structures in rat embryonic fibroblast REF52 cells. Among Rho effector molecules tested, Rhotekin induced morphological changes of septin filaments similar to those by activated Rho. The center region of Rhotekin was sufficient for the septin reorganization in the cells, and likely to interact indirectly with the C-terminal half of a septin Sept9b, where a GTPase domain is located. Rhotekin and Sept9b are colocalized mainly in perinuclear regions in serum-starved REF52 cells. Upon stimulation with lysophosphatidic acid, they translocated to actin stress fibers in 10 min and then redistributed again to cytoplasm after 90 min treatment. In neuroblastoma Neuro2a cells, Rhotekin and Sept9b were enriched in the tip of neurites, a location where cortical actin reorganization is induced upon stimulation with lysophosphatidic acid. Taken together, we propose that Rhotekin is a novel regulator organizing mammalian septin structures and provide a new link between the septin and Rho-signaling.
Introduction
Septins are a conserved family of guanine nucleotidebinding proteins forming heteropolymerized filaments, and thought to regulate various cellular events such as cytokinesis, apoptosis, vesicular transport and cell polarity (reviewed in Kartmann and Roth, 2001; Faty et al., 2002; Kinoshita, 2003) . An increasing body of data implicates the septin family in the pathogenesis of diverse disease states including neoplasia, neurodegenerative conditions, and infections (for review see Hall and Russell, 2004) . Rho is a member of another GTPase family and functions as an important regulator of cellular processes such as actin cytoskeletal remodeling, cytokinesis and cell motility (reviewed in EtienneManneville and . There are lines of evidence that implicate Rho in multiple aspects of cancer such as transformation, invasion and metastasis (reviewed in Jaffe and .
The septin assembly occurs in various cultured mammalian cells as accessory bundles tightly associated with the actin-based structures such as contractile ring, cortical actin and stress fibers (reviewed in Trimble, 1999; Kinoshita, 2003) . Although the molecular bases of interactions between the septin and actin are largely unknown, anillin was recently identified as an adaptor protein linking actin and septin filaments (Kinoshita et al., 2002) . While anillin seems to be important as a physical and structural linker in the actin-septin interaction during mitosis, an unknown adaptor protein is thought to recruit septins to actin filaments in interphase cells.
We just recently identified a Rho-specific guanine nucleotide exchange factor, SA-RhoGEF as a possible component interconnecting septin filaments and Rhosignals (Nagata and Inagaki, 2005) . Association of SA-RhoGEF with Sept9b along with stress fibers in growing REF52 cells may provide a clue to elucidate the physiological relationship among actin, septins and Rho-signaling. Interestingly, SA-RhoGEF induced septin filament disruption concomitant with actin filament reorganization, suggesting that Rho-dependent signal transduction pathways control not only actin cytoskeleton but also septin filament morphology (Nagata and Inagaki, 2005) . In this report, we identified Rhotekin, a downstream effector for Rho, as a candidate regulator organizing septin structures through filament disruption.
Results and discussion
To confirm the effects of Rho signaling on the septin filament structure, we tested if an activated version of Rho has effects on the septin filaments similar to those by SA-RhoGEF (Nagata and Inagaki, 2005) . As expected, expression of L63Rho disrupted the Sept9b-containing septin filament structure and induced a redistribution of Sept9b into a vesicular pattern localized in cytoplasm (Figure 1a and b) . In contrast, wild type Rho and activated Rac had little effects on the filament structure (Figure 1c-f) . As reported previously, expression of activated Cdc42 caused structural change of septin filaments maybe through the effects on Borg proteins (Joberty et al., 2001) , although some filaments were still observed (Figure 1g and h). Since activated versions of Rho and Cdc42 induced changes of Sept9b distribution, we carried out detailed analyses and found that the L63Rho-mediated structural change of septin filaments occurred throughout the cytoplasm (Figure  1i-l) . On the other hand, the same analyses revealed that filament disruption by L61Cdc42 was obvious in cytoplasm while the filament structure was still retained near the bottom confocal plane of the cell ( Figure  1m-p) . These results suggest that yet unidentified Rho effector molecule(s) regulates septin filament structures in REF52 cells.
To identify the Rho-effector molecule(s) responsible for the septin filament reorganization, we expressed several effectors so far identified and analyzed their effects on the septin filament structure in REF52 cells. Consequently, expression of Rhotekin induced characteristic alteration of the Sept9b-containing septin filament structure (Figure 2A , Ca and b). It should be noted that B70% of REF52 cells expressing wild-type Rhotekin showed a neuron-like collapsed form, maybe due to cell retraction (data not shown). However, septin filament disruption was observed in B80% of the Rhotekin-expressing cells with normal cell morphology ( Figure 2D ). In contrast, active ROCK (Rho kinase), citron kinase and Protein kinase N (PKN) had no observable effects on the filament structure (data not shown). Rhotekin was first identified as a Rho-specific target protein (Reid et al., 1996) , containing an active Rho-binding domain (RBD) at the N-terminus, a pleckstrin-homology (PH) domain at the central region and two proline-rich motifs at the C-terminal region ( Figure 2A ). It is notable that the Rhotekin C-terminal end fits the class I PDZ ligand consensus sequence, (S/T)X(V/I/L), where X is any amino acid. In addition to the septin filament disruption, wild-type Rhotekin highly reduced stress fibers in the cells maybe owing to sequestration of active Rho by RBD of Rhotekin (Figure 2Cc ). These results raised the possibility that apparent septin filament disruption by Rhotekin is caused as a secondary effect of sequestration of active Rho in the cells. We thus tested the effects of a Rhotekin mutant lacking RBD, DRBD, on septin filament structures. DRBD is expected to keep active Rho level Figure 2Cd -f, D and E, DRBD induced septin filament disruption with little effects on stress fibers, showing that the septin filament disruption by Rhotekin is not due to inhibition of endogenous Rho activity. Unlike cells expressing wildtype Rhotekin, the collapsed neuron-like shape was no longer observed in cells expressing DRBD (data not shown), suggestive that the sequestration of active Rho is at least partly responsible for the phenotype.
Next, to determine the region in Rhotekin essential for septin filament disruption, Rhotekin fragments as shown in Figure 2B were expressed in REF52 cells. Effects of them on the septin filament structure were then analyzed and compared to those on stress fibers. Consequently, the center region of Rhotekin, in which any domain or motif so far reported is not present, was found to induce septin filament disruption (Figure 2Cg and h, and D). It is notable that stress fibers were little affected by the center domain (Figure 2Ci and E). The C-terminal fragment had no effects on both septin and actin filament structures (Figure 2Cj -l, D, and E). About 60% of the cells expressing RBD also showed collapsed morphology similar to that observed in cells expressing wild-type Rhotekin (data not shown). This result indicates that basal Rho activity is essential for normal flat shape of REF52 cells. RBD-expressing cells Figure 2Cm and o, and E). As expected, in such cells septin filament structure was disrupted ( Figure 2Cn , and D). The observed results indicate that septin filament structure in REF52 cells is dependent on stress fibers as shown recently (Nagata et al., 2004) .
Although basal Rho activity enough for maintaining stress fibers is required for septin filament structures, excessive activation of Rho (e.g. expression of L63Rho) in REF52 cells induces actin reorganization ( Figure 2F ) simultaneously with septin filament disruption ( Figure  1a and b). Based on these observations, Rho seems to have different effects on actin and septin filaments in the cell. Although the underlying molecular mechanisms remain to be elucidated, we assume that Rho regulates actin and septin filaments bifurcately at the effector level in REF52 cells and Rhotekin is not involved in actin filament reorganization. Quantitative analyses of septin filament disruption as well as actin filament phenotypes induced by the Rhotekin and its mutants are shown in Figure 2D and E. Compared to wild-type Rhotekin, DRBD and Cent, RBD had less effects on septin and actin filaments, since disappearance of these filaments were not observed in cells expressing low amount of RBD (data not shown). Although both L63Rho and Rhotekin induced septin reorganization, the possibility still cannot be ruled out that Rhotekin-mediated septin filament disruption is independent of Rho activity.
Rhotekin-dependent septin filament reorganization suggests physical interaction of Rhotekin with septin(s). To test this possibility, FLAG-Sept9b, -Sept11, -Sept8, -Sept2 and -Sept6 were expressed with Myc-Rhotekin in COS7 cells, and immunoprecipitation analyses were carried out. Figure 3A shows that Rhotekin can be coimmunoprecipitated specifically with Sept9b, but not with Sept11, Sept8, Sept2 and Sept6 under the conditions used. However, it should be noted that direct binding of Rhotekin with Sept9b has not been so far observed in yeast two-hybrid and in vitro pull-down analyses using purified recombinant proteins (data not shown). It is thus likely that the interaction between Rhotekin and Sept9b observed in COS7 cells is indirect, and yet unidentified molecule(s) in the cell will function as a linker between Rhotekin and Sept9b.
Immunofluorescent analyses were then performed to confirm the interaction. Rhotekin per se expressed in COS7 cells distributed in a vesicular pattern in the cytoplasm as well as nucleus (Figure 3Ba) . Surprisingly, Myc-Rhotekin became to be colocalized with FLAGSept9b in a filamentous pattern when they are coexpressed (Figure 3Bb-d) , although overexpressed Rhotekin disrupted endogenous Sept9b-containing septin filaments in REF52 cells (Figure 2Ca and b) . We assume that the observed discrepancy was may be due to the different properties between endogenous septin filaments and ones consisting of exogenously expressed septins. On the other hand, Rhotekin expressed with Sept11 or Sept7 caused neither disruption of the septin filaments nor colocalization with them (Figure 3Be-j) . Although the precise molecular mechanisms involving the apparently confusing phenotypes are enigmatic, our results imply that Sept9 may play a role in the interaction between Rhotekin and septin filaments in the cell. Although further studies are required to elucidate the molecular mechanism of the Rhotekin-septin interaction, it is worth identifying the domains in Rhotekin and Sept9b essential for their interaction. We first tested if the two splicing variants of Sept9, Sept9a and Sept9c (corresponding to aa147-568 of Sept9b, Figure 4C ), interact with Rhotekin in COS7 cell expression system. As shown in Figure 4A , these variants were coimmunoprecipitated with Rhotekin. The N-terminal fragment did not form complex with Rhotekin ( Figure 4B ) and we concluded that C-terminal half of Sept9b interacts with Rhotekin ( Figure 4D ). The C-terminal region includes GTPase domain conserved among septins, and should also contain the Sept9-specific amino-acid sequence(s) responsible for the interaction with Rhotekin although further analyses are required to identify the sequence(s). It is notable that the N-terminal divergent region, with which SA-RhoGEF (Nagata and Inagaki, 2005) and some septins (Nagata et al., 2004) associate, is not required for the interaction with Rhotekin. Next, immunoprecipitation was performed to determine the region in Rhotekin essential for interaction with Sept9. As shown in Figure 4C and E, the center region of Rhotekin (Cent; aa89-334) was sufficient for interaction with Sept9b. No functional or structural domains so far categorized exist in this region.
To explore the functional relationship between Rhotekin and Sept9b, we developed a rabbit polyclonal antibody (anti-Rhotekin-N). Affinity-purified anti-Rhotekin-N detected Myc-Rhotekin expressed in COS7 cells with an apparent molecular mass of 66 kDa by Western blotting ( Figure 5A, lanes 1 and 3) . Preincubation of the antibody with the antigen inhibited the immunoreactivity, showing the specificity of the antibody ( Figure 5A , lanes 2 and 3). We then detected endogenous Rhotekin in lysates from various cell lines including REF52 and neuroblastoma Neuro2a ( Figure 5B ). Since Sept9b is also expressed in these two cell lines ( Figure 5C ), it is likely that endogenous Rhotekin and Sept9b are colocalized in these cells. To test this possibility, we examined the subcellular localization of Rhotekin in REF52 and Neuro2a cells, using a confocal microscope. As shown in Figure 5Da -c, Rhotekin was localized along with stress fibers as well as at nucleus and perinuclear region in REF52 cells. Since Sept9b is also distributed along with stress fibers (Nagata and Inagaki, 2005, and Figure 6A ), we concluded that Rhotekin and Sept9b are colocalized along with stress fibers in growing REF52 cells. In Neuro2a cells, Rhotekin was distributed in cytoplasm and clearly in the tip of neurites (Figure 5Dd ) where F-actin (Figure 5De and h) and Sept9 (Figure 5Dg ) are enriched. Rho was also found to be enriched in neurite tips of the cell (Togashi et al., 2000) . Taken together, septin structure and functions might be regulated through Rho/Rhotekin signals in growth cones. We next asked if endogenous Sept9b forms complexes with endogenous Rhotekin using COS7 cells, which express Sept9b among the subfamily proteins (Nagata et al., 2004) . When we immunoprecipitated endogenous Rhotekin from the cell lysate, Sept9b was detected in the immunoprecipitate ( Figure 5E ). This interaction is supposed to be indirect and yet unidentified protein(s) is likely to function as a linker, as described previously. Sept9b-containing septin filament structure in REF52 cells was dependent on actin stress fibers and it was disrupted by treatment of the cells with cytochalasin B, a specific inhibitor of actin polymerization (Nagata et al., 2004) . Based on the findings, we have questioned whether Sept9b is recruited to newly induced stress fibers when serum-starved REF52 cells are treated with lysophosphatidic acid (LPA), which activates Rho through one or more heptahelical G-protein-coupled receptors (Goetzl and An, 1998) . As shown in Figure   6Aa -c, Sept9b was localized mainly in fine dot-like patterns in cytoplasm of REF52 cells when the cells were serum-starved and had markedly decreased stress fibers. Upon stimulation with LPA for 10 min, considerable amount of Sept9b was found to translocate to newly formed stress fibers (Figure 6Ad-f) . When treated for 90 min, cells showed a contracted shape maybe due to continuous activation of Rho (Figure 6Ag-i) . In such cells, Sept9b was redistributed again into a cytoplasmic fine dot-like pattern (Figure 6Ag-i) . This result is consistent with that obtained in REF52 cells expressing an activated version of Rho (Figure 1a and b) .
Distribution pattern of Rhotekin along with stress fibers in growing REF52 cells resembles that of Sept9b. Therefore, to gain some insights into the physiological relationship between Sept9b and Rhotekin, we did the same analysis as above for Rhotekin. As shown in Figure 6B , the localization pattern of Rhotekin in serum-starved REF52 cells (Figure 6Ba-c) was similar to that observed for Sept9b (Figure 6Aa-c) . Rhotekin was also recruited to newly formed stress fibers in response to LPA stimulation for 10 min (Figure 6Bd-f) . Then, after 90 min of stimulation, Rhotekin came to redistribute into a cytoplasmic vesicular pattern ( Figure  6Bg -i) similar to that seen in the case of Sept9b (Figure  6Ag-i) . Finally, we double stained Sept9b and Rhotekin in both serum-starved and LPA-treated REF52 cells to further confirm their colocalization ( Figure 6C ). These results suggest that Sept9b and Rhotekin are colocalized during LPA treatment and their distribution along with actin stress fibers is dependent on the fibers.
In neuronal cells, LPA activates Rho to induce growth cone collapse and neurite retraction through G 12/13 -initiated pathways (for review see Govek et al., 2005) . Presence of Sept9b and Rhotekin at the neurite tip of Neuro2a cells implies involvement of these proteins in neurite extension and/or retraction. We thus examined the effects of transiently expressed Sept9b, Rhotekin or their mutants on extension or LPAdependent retraction of the neurites. First, FLAGtagged Sept9b and the truncated mutants were tested. All expressed proteins distributed throughout the soma and neurites in serum-starved conditions based on double staining with F-actin (data not shown). Sept9b and the mutants tested had no effects on the neurite formation ( Figure 7Aa , c and e, and B) and the retraction (Figure 7Ab, d and f, and B) . The same analyses were carried out using FLAG-Rhotekin and the mutants. Consequently, Rhotekin and the truncated mutants also had no effects on the neurite extension (Figure 7Ca, c, e, g, i, and D) . On the other hand, as for neurite retraction, expression of wild-type Rhotekin or RBD dramatically inhibited LPA-induced neurite retraction (Figure 7Cb and j) . We assume that the observed inhibition was due to the sequestration by RBD of endogenous active Rho that is essential for LPA-induced neurite retraction. In contrast, Rhotekin mutants without RBD did not show any effects on LPAinduced neurite retraction. Collectively, it is probable that Rhotekin and Sept9b do not play important roles in neurite extension and retraction.
Based on the results obtained in the present study, we assume the following working hypothesis. In resting REF52 cells with reduced stress fibers, Rhotekin as well as Sept9b are distributed in cytoplasm. It is not clear whether Sept9b forms complexes with other septins under the condition. Once LPA activates Rho through G-protein-coupled signal transduction pathways, Rho activates various downstream effectors including ROCK and Dia. ROCK facilitates actin cytoskeletal reorganization and forms stress fibers, in harmony with Dia (Nakano et al., 1999) . Then, Sept9b and probably some other septin molecules are recruited to stress fibers and form septin filaments along stress fibers. Concomitantly, Rhotekin also distributes to stress fibers and colocalized with Sept9b. When Rho is kept activated for a period of time, Rhotekin comes to reorganize septin structures through filament disruption. We recently reported that SA-RhoGEF is associated with septin filaments through Sept9b in REF52 cells, and proposed that septin filaments may function as scaffolds and keep SARhoGEF in an inactive state (Nagata and Inagaki, 2005) . Physiological relation between SA-RhoGEF and Rho/Rhotekin signaling in REF52 cells remains to be elucidated.
As regulators for mammalian septin organization, Borg proteins have so far been identified (Joberty et al., 2001) . Borg proteins, which were first identified as effectors for Cdc42 and TC10 (Joberty et al., 1999) , directly bind with the C-terminal regions of Sept6/7 dimers (Sheffield et al., 2003) . Borgs facilitate septin filament formation and its activity is inhibited by interaction with active Cdc42. It is notable that Borg3 shows a phenotype reminiscent of that caused by an inhibition of Rho function in fibroblast cells (Joberty et al., 1999) . It is thus tempting to speculate a possible crosstalk between Cdc42/Borgs and Rho/Rhotekin signaling, although further studies are required to clarify their possible relationship.
Materials and methods

Plasmid construction
pRK5-FLAG-Sept2, -Sept6, -Sept7, -Sept8, -Sept9b, -Sept11 and Sept9b-N (aa1-260) were produced as described (Nagata et al., 2003 (Nagata et al., , 2004 . The Rhotekin cDNA fragments, FL (aa1-551), N (aa1-334), Cent (aa89-334), C (aa335-551), RBD (aa1-88) and DRBD (aa89-551) were produced by PCR and constructed into pRK5-Myc and pRK5-FLAG. Plasmids harboring Rho GTPases were kind gifts from Dr A Hall (University College London, England). All constructs were verified by DNA sequencing.
Preparation of antibodies
Glutathione-S-transferase-fused Rhotekin-N served as the antigen. A rabbit polyclonal antibody specific for Rhotekin-N (anti-Rhotekin-N) was produced and affinity purified. Anti-Sept9 antibody was prepared as described (Nagata et al., 2003) .
Cell culture, transfection and immunofluorescence COS7, REF52 and Neuro2a cells were grown and transient transfection was carried out using the Lipofectamine method (Invitrogen) as described previously (Togashi et al., 2000; Nagata and Inagaki, 2005) . In some experiments, REF52 and Neuro2a cells were serum starved and treated with LPA for indicated times. Immunofluorescence analysis was performed as described (Nagata et al., 2003) . In brief, cells were fixed in methanol for 15 min at À201C. Cells were fixed with 3.7% formaldehyde where indicated. Anti-Rhotekin-N, anti-Sept9, monoclonal antiactin (Santa Cruz Biotech.), monoclonal
